BXRX Baudax Bio, Inc.

Baudax Bio, Inc. is a pharmaceutical company focusing on developing and commercializing products for acute care settings. The company was founded in 2015 and is headquartered in Malvern, PA.

As of 06/21/2021     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  11/22/2019
Outstanding shares:  70,244,702
Average volume:  2,203,788
Market cap:   $54,818,965
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    07160F107
ISIN:        US07160F1075
Sedol:      BK72JG7
Valuation   (See tab for details)
PE ratio:   -1.02
PB ratio:   -54.06
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy